GABRG2 rs2287622: What Your Genotype Means
The rs2287622 variant is a common genetic change located within the GABRG2 gene. It has been studied for its potential role in influencing susceptibility to generalized epilepsy by affecting the function of GABA-A receptors in the brain.
What each genotype means
Typical GABRG2 function
This genotype represents the most common genetic sequence observed at this location in the GABRG2 gene. Research indicates that this variant is part of the broader genetic landscape of GABA-A receptor function, which is essential for regulating neuronal excitability. There is no evidence suggesting this specific genotype independently confers a high risk for epilepsy.
This is the major allele genotype, found in the vast majority of individuals across all global populations.
Common variant carrier
Carrying one copy of the G allele is a common occurrence and is not considered a pathogenic mutation for epilepsy. While the GABRG2 gene is linked to seizure susceptibility, this specific common variant is generally considered a neutral polymorphism. It does not indicate a diagnosis of any neurological condition.
This heterozygous genotype is observed at moderate frequencies across diverse ancestral groups.
Common variant carrier
This genotype represents the minor allele homozygote at this position. Current scientific literature does not classify this common variant as a primary driver of epilepsy or neurodevelopmental disorders. It is considered a normal variation in the human genome that does not require clinical intervention.
This genotype is less common than the AA or AG configurations but is still widely distributed across global populations.
Understanding the rs2287622 Variant
The rs2287622 variant is a single nucleotide polymorphism (SNP) located within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is situated in a region of the genome that provides instructions for building the gamma-2 subunit of the GABA-A receptor. Because this variant is common in the general population, researchers have investigated whether it contributes to differences in how these receptors function or how they are expressed in the brain. While many SNPs have no observable effect on health, scientists study variants like rs2287622 to determine if they play a role in complex neurological conditions, such as epilepsy, where the balance of brain signaling is critical.
The Role of the GABRG2 Gene
The GABRG2 gene is essential for the proper function of the nervous system. It encodes the gamma-2 subunit of the GABA-A receptor, which is a type of protein complex found on the surface of neurons. GABA-A receptors act as the primary inhibitory system in the brain, meaning they help 'calm' neuronal activity by allowing chloride ions to enter cells, which makes them less likely to fire electrical signals. These receptors are pentameric, meaning they are composed of five subunits that must assemble correctly to form a functional channel. When the GABRG2 gene is altered, it can potentially disrupt the assembly, trafficking, or stability of these receptors at the synapse. Proper GABAergic signaling is vital for maintaining a balance between excitation and inhibition in the brain, and disruptions in this process are a known factor in various seizure disorders.
Research and Evidence Strength
The association between GABRG2 and epilepsy is well-established in clinical genetics, particularly regarding rare, pathogenic mutations that cause severe epileptic encephalopathies. However, the evidence for the common variant rs2287622 is considered moderate. Research in this area often involves genome-wide association studies (GWAS) that look for statistical links between specific genetic markers and epilepsy phenotypes. While some studies have suggested that variants in GABRG2 may influence susceptibility to generalized epilepsy, the effect size of any single common variant is typically small. It is important to note that epilepsy is a complex, polygenic condition, meaning it is influenced by many different genes and environmental factors. Therefore, the presence of this variant does not mean an individual will develop epilepsy, and it is not used as a standalone diagnostic tool in clinical practice.
Interpreting Your Genetic Information
If you have information about your rs2287622 genotype, it is important to view it within the context of your overall health and family history. Because this variant is common and its association with epilepsy is based on statistical trends rather than a direct cause-and-effect relationship, it cannot be used to predict a medical diagnosis. Genetic testing results should never be used to make personal health decisions or to alter medications without the direct guidance of a qualified healthcare professional. If you have concerns about epilepsy, seizure history, or neurological symptoms, you should consult with a neurologist or a genetic counselor. They can help interpret your results, discuss the limitations of current genetic research, and provide appropriate medical advice tailored to your specific clinical situation.
How common is this variant?
The rs2287622 variant is considered a common polymorphism, with the A and G alleles appearing at varying frequencies across different global ancestral populations.
Frequently asked questions
Does having the rs2287622 variant mean I have epilepsy?
No. This variant is a common genetic marker and is not a diagnostic test for epilepsy. Epilepsy is a complex condition influenced by many genetic and environmental factors.
What is the GABRG2 gene responsible for?
The GABRG2 gene provides instructions for making a subunit of the GABA-A receptor. This receptor is crucial for inhibitory signaling in the brain, which helps regulate neuronal activity.
Should I be worried about my rs2287622 result?
There is no reason for concern based on this variant alone. It is a common variation found in many healthy individuals and is not considered a definitive cause of disease.
Can I use this information to change my medication?
Absolutely not. You should never change or stop any medication based on genetic test results without consulting your doctor or pharmacist first.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2287622?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.